Clinical Trials Browser

Phase 1/2 × Withdrawn × Temozolomide × Clear all

NCT02065466 2016-04-21

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Phase 1/2 Withdrawn

CNSDermatologic

Brain Neoplasms, Melanoma

NCT00021307 2013-07-11

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Withdrawn

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma